Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. - Wikidata - awgldk - TriplyDB

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

http://www.wikidata.org/entity/Q33520447

about

A Review: Proteomics in Nasopharyngeal Carcinoma A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass.Quadratic variance models for adaptively preprocessing SELDI-TOF mass spectrometry data Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers.Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms.Selective enrichment and sensitive detection of peptide and protein biomarkers in human serum using polymeric reverse micelles and MALDI-MS Reproducibility and concordance of differential DNA methylation and gene expression in cancer.Association between protein signals and type 2 diabetes incidence Mass-spectrometry-based clinical proteomics--a review and prospective.Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.Biomarker analysis of stored blood products: emphasis on pre-analytical issues Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.Potential role of proteomics in the diagnosis of lymphoma: a meta-analysis.Identification of potential prognostic markers for knee osteoarthritis by serum proteomic analysis Nanofabrication for the analysis and manipulation of membranes.Rapid detection of wild-type and mutated transthyretins.Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer Proteomic strategies and challenges in tumor metastasis research.Screening for colorectal cancer: established and emerging modalities.Monocyte/macrophage proteomics: recent findings and biomedical applications.Proteomics: a new way to improve human African trypanosomiasis diagnosis?The 'Omics Revolution in CHO Biology: Roadmap to Improved CHO Productivity.Genomics and proteomics in liver fibrosis and cirrhosis.Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages Discovery of biomarkers for endometrial cancer: current status and prospects.A protein profile study to discriminate CIN lesions from normal cervical epithelium.Urinary proteomics analysis based on mass spectrometry and identification of therapeutic targets of Shenkangling interventions in rats with adriamycin nephropathy using iTRAQ

P2860

Q26800017-7B971E46-99F1-4EE5-BB35-AE1AD3819DDA Q30528206-3DB37FC5-13AB-47B7-973A-F1CAA9137CC1 Q33717544-BEBA0419-577F-4856-A339-93FFE4606C34 Q34022213-B0F16588-64EF-4063-92B3-552E2769CEDD Q34056239-26A896AA-0724-4534-867D-99C7A6857A58 Q34109421-798CD279-CA04-46FD-A11E-483885186EC7 Q34123835-5CA3CB57-6200-4593-B41F-FD15F1AAA597 Q34152210-F35B52BF-862B-4AD4-96B3-E405E260A9D2 Q34252113-1641F4D2-D48C-47C6-ABC8-ACFE461FAB73 Q34330358-68171581-9D6D-4D16-9751-674E52FB930D Q34396142-BDD1504D-9CDF-42A3-B7BC-14585376BEEB Q34443976-DF024571-4F57-49D9-809C-F566C311B4DC Q34502670-7189F14D-C50B-4553-A18A-3F7DEC57D591 Q34916224-430274CA-D9A0-46BD-9899-2E6DB5AE3046 Q35153713-337FFAE6-8688-4FB6-BAD5-8A0091A16176 Q35765201-51EE2BF1-DD9B-4CE5-90E6-93A32F305C6B Q36057205-EED6B990-6011-4CD4-8F18-F1BE5B4F1E37 Q36582422-3C18BCE8-C307-4DD4-A430-B8C171B28A82 Q37094396-8416F494-782F-4A2A-8B6D-36C435C874EF Q37770437-1B8A1A50-B8AE-468E-9266-BAED7301F9B3 Q37951776-4F35D973-FBE3-4045-9266-B9BE41EFEB6A Q37998532-C60FBF85-40C3-401F-B1D4-6146D997752D Q38115332-2EE1ED48-9890-4282-B1AF-2C58FF421DA1 Q38703961-637325C8-7F1D-45D4-9BFA-75E6BAC093E5 Q40462698-10717EAF-66AA-45C7-8AB2-5191895B5F5E Q41421784-AA6035B5-A981-4B0B-985C-2D0D11228033 Q51341963-D8FD1317-DA21-494C-9D7C-037377343925 Q55428476-9EA8136C-00A4-46E6-B832-8F16D05CA6F6 Q57175918-3C4569BE-F614-444A-8BF3-D7973999F77B

P2860

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

http://www.wikidata.org/entity/Q33520447

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@ast

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@en

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@nl

type

label

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@ast

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@en

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@nl

prefLabel

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@ast

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@en

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@nl

P1433

Q33520447-BA0935EC-E105-4ADF-8530-C9F27DEAC72E

P1476

Q33520447-A9CA115E-BF56-43A1-A1C1-5E1CCBB7D656

P2093

Q33520447-13537DF5-F0AA-46C5-98F4-3FD6E5E5B44F

Q33520447-7694C50C-BCBB-4AE0-90D3-FCF7BF8FAC5A

Q33520447-8D25124B-3CC2-4186-A9C4-B59CA009FC37

Q33520447-9244DD27-D1CD-4589-93C6-6A5B6B4FA49C

Q33520447-A5ADB7AA-FEE9-4966-8D29-BEDDB053DE1C

Q33520447-F6602624-F605-4014-916E-0A0AB2F26040

P2860

Q33520447-008D2C3F-7D73-423E-80C5-324D48A2E72D

Q33520447-029383EE-CD7A-40E7-85F5-A61B1771E4A0

Q33520447-035819F7-D7A8-4685-B556-6993735753E5

Q33520447-0362F730-ADFE-4C84-B983-60C4E16EE0A9

Q33520447-0ABA3DBE-CD6B-42C7-A51C-C2C35E8930CE

Q33520447-0E2A7795-AEA2-4F4F-BE8F-0F4315386872

Q33520447-10D0D293-4E94-4BC6-A1CC-8D19A2676F9D

Q33520447-1274A076-A3BF-4EC1-8E4C-0D51D0AFC560

Q33520447-157A1EB9-9A9C-463B-9275-AC06546F3A4B

Q33520447-1650E5A9-7303-4C72-963E-DA7C78B62E43

P304

Q33520447-5D03A2FA-3322-4D4E-BABC-1C8661C2BDD5

P31

Q33520447-2E3DC85F-8905-4E7E-A74D-E8BDDF38CF1D

Q33520447-92F12A9E-8F2B-4536-9FA8-A665359EBC04

P356

Q33520447-AF938970-916C-43F0-A7D7-6FB6396130DD

P478

Q33520447-2D54405A-4FDA-4FE0-A190-60D2DF2AC9EE

P50

Q33520447-337C8895-90E2-4A7E-A3CA-B453860BA926

Q33520447-97941AB9-C40B-4680-A5E3-F1CC1BC6D9FD

Q33520447-CA3229C4-0C90-4B2C-AA1E-1E504DBE639C

P577

Q33520447-48336A96-3534-48A4-9BEF-45F06A54F1BB

P5875

Q33520447-1A5B0D69-BDBF-49D4-BCF7-8656D970CEF3

P698

Q33520447-00DFE797-4BED-4A7E-869F-1678E25F76DF

P921

Q33520447-2B8F347B-2707-4DD8-AF67-3AE2C990FE02

Q33520447-34FB53C0-EE4F-4623-9060-6A6B3E6EF169

Q33520447-3D5BA922-5476-4825-9D6F-18DB2A71F16D

P932

Q33520447-22BAFE13-1CAE-40BE-981C-E5033A8927D9

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

@en

P2093

Dominique de Seny

http://www.w3.org/2001/XMLSchema#string

Edouard Louis

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Chapelle

http://www.w3.org/2001/XMLSchema#string

Marie-Paule Merville

http://www.w3.org/2001/XMLSchema#string

Michel Malaise

http://www.w3.org/2001/XMLSchema#string

Muriel De Bock

http://www.w3.org/2001/XMLSchema#string

P2860

Current two-dimensional electrophoresis technology for proteomics

Current developments in SELDI affinity technology

Clinical proteomics: written in blood

The human plasma proteome: history, character, and diagnostic prospects

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices

Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth

Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis

Classification-based comparison of pre-processing methods for interpretation of mass spectrometry generated clinical datasets.

P304

906082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/906082

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

Marie-Alice Meuwis

Marie-Paule Merville

Marianne Fillet

P577

2009-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40760121

http://www.w3.org/2001/XMLSchema#string

P698

20029632

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

fluids and secretions

P932

2793423

http://www.w3.org/2001/XMLSchema#string